SUCCESSFUL ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH IBRUTINIB REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on

Molica, S
Matutes, E
Tam, C
Polliack, A

December 2019

A major revolution in the treatment of chronic lymphocytic leukemia (CLL) began with the approval of...

Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

Quaglia F. M.
Rigolin G. M.
Saccenti E.
Negrini M.
Volta E.
Dabusti M.
Ciccone M.
Urso A.
Laudisi M.
Cuneo A.

January 2019

In 2014 a 66-year-old woman presented with anemia and an IgAk monoclonal spike. Bone marrow (BM) bio...

SUCCESSFUL HEMATOPOIETIC STEM CELL MOBILIZATION IN A MULTIPLE MYELOMA PATIENT AFTER TWENTY-FOUR CYCLES OF LENALIDOMIDE

Celebi, T.
Patir, P.
Soyer, N.
Sahin, F.
Saydam, G.

January 2016

7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYWOS: 0003911806...

IBRUTINIB EXPERIENCE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: SINGEL CENTER EXPERIENCE

Uysal, A.
Soyer, N. Akad
Patir, P.
Duran, M.
Koseoglu, F. D.
Sahin, F.
Vural, F.
Tombuloglu, M.
Saydam, G.

January 2016

7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYWOS: 0003911806...

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Schaap, M.
Montoto, Silvia
Schetelig, Johannes

January 2019

Contains fulltext : 201051.pdf (publisher's version ) (Closed access

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma:a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Nagler, Arnon
Scheid, Christof
Cornelissen, Jan
Niederwieser, Dietger
Mueller, Lutz
Vandenberghe, Elizabeth
Scortechini, Ilaria
Schoemans, Helene
Andersen, Niels S.
Finke, Juergen
Russo, Domenico
Ljungman, Per
Passweg, Jakob
van Gelder, Michel
Durakovic, Nadira
Labussiere-Wallet, Helene
Berg, Tobias
Wulf, Gerald
Bethge, Wolfgang
Bunjes, Donald
Stilgenbauer, Stefan
Canepari, Maria Elisa
Schaap, Michel
Fox, Christopher P.
Kroeger, Nicolaus
Montoto, Silvia
Schetelig, Johannes

January 2019

The aim of this retrospective study was to investigate the safety and efficacy of allogeneic hematop...

Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature

Arcari Annalisa
Bassi Simona
Pochintesta Lara
Trabacchi Elena
Moroni Carlo Filippo
Rossi Angela
Zanlari Luca
Vallisa Daniele

January 2017

The treatment landscape of chronic lymphocytic leukemia (CLL) has been challenged by the advent of n...

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

M. Michallet
P. Dreger
M. Sobh
L. Koster
J. Hoek
A. Boumendil
C. Scheid
C.P. Fox
G. Wulf
W. Kruger
M. van Gelder
P. Corradini
D. Russo
J. Passweg
H. Schoemans
W. Bethge
N. Schaap
J. Cornelissen
P. Browne
N. Durakovic
L. Muller
S. Montoto
N. Kroger
J. Schetelig

January 2019

The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage tr...

HODGKIN LYMPHOMA TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

Dincyurek, Huseyin Derya
Mutlu, Yasa Gul
Kis, Cem
Guvenc, Birol

January 2017

8th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 18-21, 2017 -- Istanbul, TURKE...

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT

Ryan, CE
Sahaf, B
Logan, AC
OBrien, S
Byrd, JC
Hillmen, P
Brown, JR
Dyer, MJS
Mato, AR
Keating, MJ
Jaglowski, S
Clow, F
Rezvani, AR
Styles, L
Coutre, SE
Miklos, DB

December 2016

Ibrutinib, a potent and irreversible small-molecule inhibitor of both Bruton’s tyrosine kinase and i...

Stem cell transplantation for non-hodgkin's lymphoma (NHL)

De Souza, Carmino

May 2021

Sem informação611S11S128. International Eurasian Hematology Oncology Congress (EHOC)2017-10-18Istanb...

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak, Anil
Tanrikulu, Funda Pepedil
Durusoy, Salih Sertac
Gurkan, Emel
Kaya, Emin
Umit, Elif G.
Terzi, Hatice

January 2019

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 --...

Allogeneic haematopoietic stem cell transplantation in adult aplastic anemia patients

Davulcu, E. Arslan
Bulbul, H.
Ulusoy, Y.
Atilla, F.
Soyer, N.
Sahin, F.
Tobu, M.
Saydam, G.
Tombuloglu, M.
Vural, F.

January 2018

9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKE...

EXPERIENCE WITH IBRUTINIB IN PATIENTS WITH REFRACTORY AND RECURRENT B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

T. V. SOROKINA
S. R. GORYACHEVA
V. A. SPIRINA
L. S. AL-RADI
T. N. OBUKHOVA
B. V. BIDERMAN
T. N. MOISEEVA

June 2017

Purpose of the study. To obtain experience with ibrutinib in patients with chronic lymphocytic leuke...

The Difficult-to-Treat del 17 p Patient—A Case Report in Chronic Lymphocytic Leukemia

Ana-Maria Moldovianu
Ana Manuela Crisan
Zsofia Varady
Daniel Coriu

December 2021

Chronic lymphocytic leukemia (CLL) treatment strategies have evolved to include mechanism-driven dru...

Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on

Molica, S
Matutes, E
Tam, C
Polliack, A

December 2019

A major revolution in the treatment of chronic lymphocytic leukemia (CLL) began with the approval of...

Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

Quaglia F. M.
Rigolin G. M.
Saccenti E.
Negrini M.
Volta E.
Dabusti M.
Ciccone M.
Urso A.
Laudisi M.
Cuneo A.

January 2019

In 2014 a 66-year-old woman presented with anemia and an IgAk monoclonal spike. Bone marrow (BM) bio...

SUCCESSFUL HEMATOPOIETIC STEM CELL MOBILIZATION IN A MULTIPLE MYELOMA PATIENT AFTER TWENTY-FOUR CYCLES OF LENALIDOMIDE

Celebi, T.
Patir, P.
Soyer, N.
Sahin, F.
Saydam, G.

January 2016

7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYWOS: 0003911806...

IBRUTINIB EXPERIENCE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: SINGEL CENTER EXPERIENCE

Uysal, A.
Soyer, N. Akad
Patir, P.
Duran, M.
Koseoglu, F. D.
Sahin, F.
Vural, F.
Tombuloglu, M.
Saydam, G.

January 2016

7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYWOS: 0003911806...

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Schaap, M.
Montoto, Silvia
Schetelig, Johannes

January 2019

Contains fulltext : 201051.pdf (publisher's version ) (Closed access

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma:a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Nagler, Arnon
Scheid, Christof
Cornelissen, Jan
Niederwieser, Dietger
Mueller, Lutz
Vandenberghe, Elizabeth
Scortechini, Ilaria
Schoemans, Helene
Andersen, Niels S.
Finke, Juergen
Russo, Domenico
Ljungman, Per
Passweg, Jakob
van Gelder, Michel
Durakovic, Nadira
Labussiere-Wallet, Helene
Berg, Tobias
Wulf, Gerald
Bethge, Wolfgang
Bunjes, Donald
Stilgenbauer, Stefan
Canepari, Maria Elisa
Schaap, Michel
Fox, Christopher P.
Kroeger, Nicolaus
Montoto, Silvia
Schetelig, Johannes

January 2019

The aim of this retrospective study was to investigate the safety and efficacy of allogeneic hematop...

Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature

Arcari Annalisa
Bassi Simona
Pochintesta Lara
Trabacchi Elena
Moroni Carlo Filippo
Rossi Angela
Zanlari Luca
Vallisa Daniele

January 2017

The treatment landscape of chronic lymphocytic leukemia (CLL) has been challenged by the advent of n...

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

M. Michallet
P. Dreger
M. Sobh
L. Koster
J. Hoek
A. Boumendil
C. Scheid
C.P. Fox
G. Wulf
W. Kruger
M. van Gelder
P. Corradini
D. Russo
J. Passweg
H. Schoemans
W. Bethge
N. Schaap
J. Cornelissen
P. Browne
N. Durakovic
L. Muller
S. Montoto
N. Kroger
J. Schetelig

January 2019

The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage tr...

HODGKIN LYMPHOMA TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

Dincyurek, Huseyin Derya
Mutlu, Yasa Gul
Kis, Cem
Guvenc, Birol

January 2017

8th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 18-21, 2017 -- Istanbul, TURKE...

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT

Ryan, CE
Sahaf, B
Logan, AC
OBrien, S
Byrd, JC
Hillmen, P
Brown, JR
Dyer, MJS
Mato, AR
Keating, MJ
Jaglowski, S
Clow, F
Rezvani, AR
Styles, L
Coutre, SE
Miklos, DB

December 2016

Ibrutinib, a potent and irreversible small-molecule inhibitor of both Bruton’s tyrosine kinase and i...

Stem cell transplantation for non-hodgkin's lymphoma (NHL)

De Souza, Carmino

May 2021

Sem informação611S11S128. International Eurasian Hematology Oncology Congress (EHOC)2017-10-18Istanb...

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak, Anil
Tanrikulu, Funda Pepedil
Durusoy, Salih Sertac
Gurkan, Emel
Kaya, Emin
Umit, Elif G.
Terzi, Hatice

January 2019

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 --...

Allogeneic haematopoietic stem cell transplantation in adult aplastic anemia patients

Davulcu, E. Arslan
Bulbul, H.
Ulusoy, Y.
Atilla, F.
Soyer, N.
Sahin, F.
Tobu, M.
Saydam, G.
Tombuloglu, M.
Vural, F.

January 2018

9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKE...

EXPERIENCE WITH IBRUTINIB IN PATIENTS WITH REFRACTORY AND RECURRENT B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

T. V. SOROKINA
S. R. GORYACHEVA
V. A. SPIRINA
L. S. AL-RADI
T. N. OBUKHOVA
B. V. BIDERMAN
T. N. MOISEEVA

June 2017

Purpose of the study. To obtain experience with ibrutinib in patients with chronic lymphocytic leuke...

The Difficult-to-Treat del 17 p Patient—A Case Report in Chronic Lymphocytic Leukemia

Ana-Maria Moldovianu
Ana Manuela Crisan
Zsofia Varady
Daniel Coriu

December 2021

Chronic lymphocytic leukemia (CLL) treatment strategies have evolved to include mechanism-driven dru...

Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on

Molica, S
Matutes, E
Tam, C
Polliack, A

December 2019

A major revolution in the treatment of chronic lymphocytic leukemia (CLL) began with the approval of...

Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

Quaglia F. M.
Rigolin G. M.
Saccenti E.
Negrini M.
Volta E.
Dabusti M.
Ciccone M.
Urso A.
Laudisi M.
Cuneo A.

January 2019

In 2014 a 66-year-old woman presented with anemia and an IgAk monoclonal spike. Bone marrow (BM) bio...

SUCCESSFUL HEMATOPOIETIC STEM CELL MOBILIZATION IN A MULTIPLE MYELOMA PATIENT AFTER TWENTY-FOUR CYCLES OF LENALIDOMIDE

Celebi, T.
Patir, P.
Soyer, N.
Sahin, F.
Saydam, G.

January 2016

7th International Eurasian Hematology Congress -- OCT 13-16, 2016 -- Istanbul, TURKEYWOS: 0003911806...

SUCCESSFUL ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH IBRUTINIB REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

Abstract

Extracted data

SUCCESSFUL ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH IBRUTINIB REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

Abstract

Extracted data

Related items

Related items